Samsung Biologics to acquire Swiss-based CDMO firm for 2.7 tln won
--------------------------------------------------------------------
Source: South Korea
Published: 2026-07-20 10:55 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Property, South Korea, World News
--------------------------------------------------------------------
Snippet:
SEOUL, July 20 (Yonhap) -- Samsung Biologics Co. said Monday it will acquire a Swiss-based contract development and manufacturing organization (CDMO) for 2.7 trillion won (US$1.8 billion) as part of its global expansion strategy.
--------------------------------------------------------------------